Literature DB >> 31691299

Positive node-ratio in curative-intent treatment for gastric cancer is a strong independent prognostic factor for 5-year overall survival.

Durval R Wohnrath1, Raphael L C Araujo1,2,3,4.   

Abstract

INTRODUCTION: This study addressed whether the positive node-ratio (N-ratio) for patients who underwent curative-intent treatment was an independent prognostic factor of overall survival (OS) for gastric adenocarcinoma (GA).
METHODS: Consecutive patients who underwent gastrectomy for GA with at least 15 harvested nodes were evaluated for 5-year OS. The best threshold was determined using the area under an receiver operating characteristic (ROC) curve. Univariate and multivariate models were assessed looking for independent prognostic factors for OS.
RESULTS: From 1994 to 2015, 398 consecutive patients were evaluated. The N-ratio ≥11% had an accuracy of 0.764, the sensitivity of 71.1%, the specificity of 81.7%, positive predictive value (PPV) of 91.7%, and odds ratio (OR) of 11. After multivariate analysis for OS, age ≥70 years (HR 1.44), need for total gastrectomy (HR 1.45), need for extended resection (HR 1.7), and N-ratio ≥11% (HR 3.7) were unfavorable prognostic factors. D2 lymphadenectomy (HR 0.53) was a protective factor. The median OS according to N-ratio was 14 months for N-ratio >11 vs 58 months for N-ratio <11%.
CONCLUSION: The N-ratio ≥11% was an independent negative prognostic factor for patients who underwent treatment for GA with curative intent. The N-ratio ≥11% presented high specificity, high PPV and high OR for risk of death for 5 years after surgery.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  gastric cancer; lymphadenectomy; oncologic outcomes; surgery; survival

Mesh:

Year:  2019        PMID: 31691299     DOI: 10.1002/jso.25755

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  5 in total

1.  Retrieval of 30 Lymph Nodes Is Mandatory for Selected Stage II Gastric Cancer Patients.

Authors:  Yong-He Chen; Jun Lu; Run-Cong Nie; Dan Liu; Ai-Hong Liu; Zi-Jian Deng; Xi-Jie Chen; Jun Xiang; Ying-Bo Chen; Chang-Ming Huang; Shi Chen; Jun-Sheng Peng
Journal:  Front Oncol       Date:  2021-04-30       Impact factor: 6.244

2.  The Prognostic Value of Lymph Node Ratio after Neoadjuvant Chemotherapy in Patients with Locally Advanced Gastric Adenocarcinoma.

Authors:  Kankai Zhu; Hailong Jin; Zhijian Li; Yuan Gao; Qing Zhang; Xiaosun Liu; Jiren Yu
Journal:  J Gastric Cancer       Date:  2021-03-24       Impact factor: 3.720

3.  A Novel Approach for Gastric Cancer Staging in Elderly Patients Based on the Lymph Node Ratio.

Authors:  Joonseon Park; Chul Hyo Jeon; So Jung Kim; Ho Seok Seo; Kyo Young Song; Han Hong Lee
Journal:  J Gastric Cancer       Date:  2021-03-26       Impact factor: 3.720

4.  Laparoscopic gastrectomy plus D2 lymphadenectomy is as effective as open surgery in terms of long-term survival: a single-institution study on gastric cancer.

Authors:  Yawei Wang; Yan Wang; Wang Wu; Xiaofang Lu; Tailai An; Jiling Jiang
Journal:  World J Surg Oncol       Date:  2021-04-07       Impact factor: 2.754

5.  Design and Development of an Intelligent System for Predicting 5-Year Survival in Gastric Cancer.

Authors:  Mohammad Reza Afrash; Mostafa Shanbehzadeh; Hadi Kazemi-Arpanahi
Journal:  Clin Med Insights Oncol       Date:  2022-08-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.